{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:50:48Z","timestamp":1792183848860,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Jose Carreras Leukemia Foundation","award":["R09\/14"],"award-info":[{"award-number":["R09\/14"]}]},{"name":"German Jose Carreras Leukemia Foundation","award":["10\/03"],"award-info":[{"award-number":["10\/03"]}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jcyt.2014.04.003","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T14:30:45Z","timestamp":1402669845000},"page":"1325-1335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation"],"prefix":"10.1016","volume":"16","author":[{"given":"Jiju","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2014.04.003_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/10428194.2010.487960","article-title":"Viral infections following allogeneic stem cell transplantation: how to cure the cure?","volume":"51","author":"Smits","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2014.04.003_bib3","first-page":"1","article-title":"New human papovaviruses","volume":"22","author":"Padgett","year":"1976","journal-title":"Prog Med Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib4","first-page":"185","article-title":"Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy)","volume":"11","author":"Zu Rhein","year":"1969","journal-title":"Prog Med Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/infdis\/147.4.676","article-title":"Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues","volume":"147","author":"Chesters","year":"1983","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib6","series-title":"Principles and Practice of Clinical Virology","article-title":"Human polyomaviruses","author":"Doerries","year":"2004"},{"key":"10.1016\/j.jcyt.2014.04.003_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1179\/016164106X98198","article-title":"Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab","volume":"28","author":"Berger","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.jcyt.2014.04.003_bib8","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","article-title":"Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis","volume":"22","author":"De Luca","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jcyt.2014.04.003_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/374048","article-title":"Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy","volume":"36","author":"Berenguer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-199910010-00010","article-title":"Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors: Clinical Epidemiology Group, French Hospital Database on HIV","volume":"13","author":"Tassie","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jcyt.2014.04.003_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MOT.0b013e3283186b93","article-title":"Cellular immune responses to BK virus","volume":"13","author":"Comoli","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bbmt.2013.05.002","article-title":"BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Laskin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-3062.2006.00167.x","article-title":"Polyomavirus-associated nephropathy: update on BK virus-specific immunity","volume":"8","author":"Comoli","year":"2006","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 8","key":"10.1016\/j.jcyt.2014.04.003_bib14","article-title":"Cytomegalovirus and polyomavirus BK posttransplant","volume":"22","author":"Egli","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bmt.2008.266","article-title":"High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis","volume":"43","author":"Wong","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apm.12128","article-title":"The human JC polyomavirus (JCPyV): virological background and clinical implications","volume":"121","author":"Hirsch","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.jcyt.2014.04.003_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1705548","article-title":"Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature","volume":"39","author":"Kharfan-Dabaja","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3324\/haematol.2010.029876","article-title":"Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents","volume":"96","author":"Schmidt-Hieber","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2014.04.003_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression","volume":"81","author":"Gheuens","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jcyt.2014.04.003_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project","volume":"10","author":"Carson","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrrheum.2009.142","article-title":"Therapy: targeted but not trouble-free: efalizumab and PML","volume":"5","author":"Molloy","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/practneurol-2011-000092","article-title":"Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring","volume":"12","author":"Hunt","year":"2012","journal-title":"Pract Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2014.04.003_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13550280390195261","article-title":"Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions","volume":"9","author":"Berger","year":"2003","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib28","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.80.7.3495-3505.2006","article-title":"Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy","volume":"80","author":"Chen","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/01.TP.0000137932.44791.D3","article-title":"Polyomavirus BK-specific immunity after kidney transplantation","volume":"78","author":"Comoli","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2014.04.003_bib30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1600-6143.2005.01080.x","article-title":"BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis","volume":"5","author":"Hariharan","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4049\/jimmunol.160.4.1724","article-title":"Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein","volume":"160","author":"Lukacher","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/TP.0b013e31815fef56","article-title":"Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis","volume":"85","author":"Prosser","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2014.04.003_bib33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1600-6143.2007.01754.x","article-title":"Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients","volume":"7","author":"Binggeli","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib34","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","article-title":"T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus","volume":"87","author":"Li","year":"2006","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1600-6143.2005.01221.x","article-title":"HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity","volume":"6","author":"Hammer","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.humimm.2006.02.031","article-title":"Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients","volume":"67","author":"Randhawa","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib37","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/j.1600-6143.2007.01984.x","article-title":"Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients","volume":"7","author":"Ginevri","year":"2007","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2014.04.003_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.humimm.2009.05.003","article-title":"HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen","volume":"70","author":"Ramaswami","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/TP.0b013e3181fe1335","article-title":"BK-VP3 as a new target of cellular immunity in BK virus infection","volume":"91","author":"Mueller","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2014.04.003_bib40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/TP.0b013e318234e0e5","article-title":"Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity","volume":"92","author":"Trydzenskaya","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2014.04.003_bib41","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1600-6143.2011.03693.x","article-title":"BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy","volume":"11","author":"Schachtner","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib42","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/JVI.01809-06","article-title":"Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy","volume":"81","author":"Lima","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-4-47","article-title":"Characterization of highly frequent epitope-specific CD45RA+\/CCR7+\/\u2212 T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors","volume":"4","author":"Provenzano","year":"2006","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib44","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1128\/JVI.79.17.11170-11178.2005","article-title":"Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides","volume":"79","author":"Krymskaya","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/CVI.00487-10","article-title":"The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response","volume":"18","author":"Ramaswami","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"18","key":"10.1016\/j.jcyt.2014.04.003_bib46","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.1128\/JVI.01540-13","article-title":"Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults","volume":"87","author":"van Aalderen","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1016\/j.jcyt.2014.04.003_bib47","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00002030-200307040-00004","article-title":"Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy","volume":"17","author":"Gasnault","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jcyt.2014.04.003_bib48","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JVI.02657-08","article-title":"JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy","volume":"83","author":"Khanna","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib49","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1128\/JVI.78.18.10206-10210.2004","article-title":"Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals","volume":"78","author":"Du Pasquier","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/vim.2007.0030","article-title":"Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults","volume":"20","author":"Zhou","year":"2007","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bmt.1705886","article-title":"Polyomavirus BK infection in blood and marrow transplant recipients","volume":"41","author":"Dropulic","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/427291","article-title":"Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Leung","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/14787210.5.1.105","article-title":"Antivirals for the treatment of polyomavirus BK replication","volume":"5","author":"Rinaldo","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jcyt.2014.04.003_bib54","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bmt.1705678","article-title":"Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant","volume":"39","author":"Savona","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ajh.20567","article-title":"Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation","volume":"81","author":"Bridges","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1702129","article-title":"Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation","volume":"25","author":"Vianelli","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib57","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bmt.1702715","article-title":"Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation","volume":"26","author":"Seabra","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/rmv.710","article-title":"Progressive multifocal leukoencephalopathy: clinical and molecular aspects","volume":"22","author":"Tavazzi","year":"2012","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2007.03.001","article-title":"Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis","volume":"39","author":"Focosi","year":"2007","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneurol.2008.557","article-title":"Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy","volume":"66","author":"Cettomai","year":"2009","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.jcyt.2014.04.003_bib61","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","article-title":"Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis","volume":"77","author":"Vulliemoz","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jcyt.2014.04.003_bib62","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/rheumatology\/kem049","article-title":"Progressive multifocal leucoencephalopathy in a patient with sarcoidosis\u2013successful treatment with cidofovir and mirtazapine","volume":"46","author":"Owczarczyk","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jcyt.2014.04.003_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1086\/520514","article-title":"Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera","volume":"196","author":"Verma","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib64","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1212\/01.wnl.0000183064.10227.b5","article-title":"Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2","volume":"65","author":"Kunschner","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jcyt.2014.04.003_bib65","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00277-002-0481-4","article-title":"Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy","volume":"81","author":"Buckanovich","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib66","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bmt.1701010","article-title":"Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2","volume":"20","author":"Przepiorka","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib67","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000112916","article-title":"Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy","volume":"50","author":"Pohlmann","year":"2007","journal-title":"Intervirology"},{"key":"10.1016\/j.jcyt.2014.04.003_bib68","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/00002030-200209060-00012","article-title":"A\u00a0pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS","volume":"16","author":"Marra","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jcyt.2014.04.003_bib69","first-page":"526","article-title":"Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy","volume":"255","author":"Kraemer","year":"2008","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejim.2008.07.032","article-title":"Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states","volume":"20","author":"Epker","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib71","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2014.04.003_bib72","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-065X.1997.tb00983.x","article-title":"Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts","volume":"157","author":"O'Reilly","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcyt.2014.04.003_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/scd.1.1995.4.73","article-title":"Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease","volume":"4","author":"Smith","year":"1995","journal-title":"J\u00a0Hematother"},{"key":"10.1016\/j.jcyt.2014.04.003_bib75","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2014.04.003_bib77","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib78","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib79","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2014.04.003_bib80","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib81","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib82","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib83","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib84","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-10-006536","article-title":"In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes","volume":"108","author":"Park","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib85","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.168.2.909","article-title":"Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals","volume":"168","author":"Savoldo","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib86","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.vaccine.2009.01.017","article-title":"De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination","volume":"27","author":"Safdar","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jcyt.2014.04.003_bib87","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib88","first-page":"e3627","article-title":"Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus","volume":"63","author":"Hanley","year":"2012","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jcyt.2014.04.003_bib89","first-page":"305","article-title":"Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex)","volume":"33","author":"Vera","year":"2010","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.jcyt.2014.04.003_bib90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib91","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib93","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"Moosmann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","article-title":"Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation","volume":"31","author":"Icheva","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib95","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2014.04.003_bib96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00262-009-0789-1","article-title":"A\u00a0novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation","volume":"59","author":"Uhlin","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2014.04.003_bib97","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib98","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","article-title":"Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation","volume":"51","author":"Schmitt","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2014.04.003_bib99","doi-asserted-by":"crossref","first-page":"e26199","DOI":"10.4161\/onci.26199","article-title":"Adoptive immunotherapy: new assay for the identification of T cells with optimal avidity","volume":"2","author":"Weissbrich","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2014.04.003_bib100","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib101","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","article-title":"Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells","volume":"360","author":"Haque","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2014.04.003_bib102","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","article-title":"Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes","volume":"116","author":"Barker","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib103","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.003_bib104","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/bmt.2010.221","article-title":"Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient","volume":"46","author":"Balduzzi","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.003_bib105","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3109\/10428191003746323","article-title":"Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant","volume":"51","author":"Schneidawind","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2014.04.003_bib106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcv.2008.01.005","article-title":"BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy","volume":"42","author":"Chen","year":"2008","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib107","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/intimm\/dxm076","article-title":"Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML)","volume":"19","author":"Yang","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib108","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcmd.2007.07.003","article-title":"Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells","volume":"40","author":"Mackinnon","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jcyt.2014.04.003_bib109","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.immuni.2007.10.012","article-title":"A\u00a0single naive CD8+ T cell precursor can develop into diverse effector and memory subsets","volume":"27","author":"Stemberger","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2014.04.003_bib110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virol.2008.10.046","article-title":"Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy","volume":"383","author":"Marzocchetti","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jcyt.2014.04.003_bib111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2006.04.003","article-title":"JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients","volume":"176","author":"Du Pasquier","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jcyt.2014.04.003_bib112","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/01.aids.0000194804.97164.86","article-title":"Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies","volume":"19","author":"Du Pasquier","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jcyt.2014.04.003_bib113","doi-asserted-by":"crossref","first-page":"e64313","DOI":"10.1371\/journal.pone.0064313","article-title":"Detection of JC virus-specific immune responses in a novel humanized mouse model","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2014.04.003_bib114","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2006.02.040","article-title":"Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals","volume":"350","author":"Sharma","year":"2006","journal-title":"Virology"},{"issue":"Suppl 2","key":"10.1016\/j.jcyt.2014.04.003_bib115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13550280290167894","article-title":"Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy","author":"Koralnik","year":"2002","journal-title":"J\u00a0Neurovirol"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2014.04.003_bib116","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1016\/j.ymthe.2006.08.665","article-title":"Development of anti-JC virus \u2018designer T cells' for progressive multifocal leukoencephalopathy (PML) immunotherapy","volume":"13","author":"Yang","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2014.04.003_bib117","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.168.1.499","article-title":"Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope","volume":"168","author":"Koralnik","year":"2002","journal-title":"J\u00a0Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:20:14Z","timestamp":1761430814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324914005593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":117,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1465324914005593"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.04.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}